Rituximab in multiple sclerosis, a long term safety and efficacy study

被引：0
|
作者：
Islam-Jakobsson, P. [1 ]
Alping, P. [2 ]
Salzer, J. [1 ]
Bjorck, A. [2 ]
Fink, K. [2 ]
Frisell, T. [3 ]
Piehl, F. [2 ]
Svenningsson, A. [1 ]
机构：
[1] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden
[2] Karolinska Insitutet, Dept Clin Neurosci, Stockholm, Sweden
[3] Karolinska Insitutet, Dept Med, Stockholm, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1108
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [1] Rituximab in multiple sclerosis A retrospective observational study on safety and efficacy
    Salzer, Jonatan
    Svenningsson, Rasmus
    Alping, Peter
    Novakova, Lenka
    Bjorck, Anna
    Fink, Katharina
    Islam-Jakobsson, Protik
    Malmestrm, Clas
    Axelsson, Markus
    Vagberg, Mattias
    Sundstrom, Peter
    Lycke, Jan
    Piehl, Fredrik
    Svenningsson, Anders
    NEUROLOGY, 2016, 87 (20) : 2074 - 2081
  • [2] Safety and efficacy of rituximab in multiple sclerosis: A retrospective observational study
    Zeineddine, Maya
    Ayyoubi, Nabil
    Nicolas, Johny
    Khoury, Samia
    Yamout, Bassem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP21 - NP22
  • [3] Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
    Yamout, Bassem I.
    El-Ayoubi, Nabil K.
    Nicolas, Johny
    El Kouzi, Yehya
    Khoury, Samia J.
    Zeineddine, Maya M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [4] Safety and efficacy of rituximab in multiple sclerosis: a retrospective observational study
    Zeineddine, M.
    Ayyoubi, N.
    Nicolas, J.
    Khoury, S.
    Yamout, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 608 - 608
  • [5] LONG-TERM EFFICACY AND SAFETY OF RITUXIMAB IN SYSTEMIC SCLEROSIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSANTS
    Polito, P.
    Zanatta, E.
    Favaro, M.
    Felicetti, M.
    Oliviero, F.
    Pigatto, E.
    Cozzi, F.
    Doria, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1530 - 1530
  • [6] Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
    Tuohy, Orla
    Costelloe, Lisa
    Hill-Cawthorne, Grant
    Bjornson, Ingunn
    Harding, Katharine
    Robertson, Neil
    May, Karen
    Button, Tom
    Azzopardi, Laura
    Kousin-Ezewu, Onajite
    Fahey, Michael T.
    Jones, Joanne
    Compston, D. Alastair S.
    Coles, Alasdair
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 208 - 215
  • [7] Long-term efficacy and safety of transanal irrigation in multiple sclerosis
    Passananti, V.
    Wilton, A.
    Preziosi, G.
    Storrie, J. B.
    Emmanuel, A.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (09): : 1349 - 1355
  • [8] Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis
    Midaglia, Luciana
    Mora, Liliana
    Mulero, Patricia
    Sastre-Garriga, Jaume
    Montalban, Xavier
    REVISTA DE NEUROLOGIA, 2018, 66 (01) : 25 - 32
  • [9] Safety and Efficacy of Rituximab: Experience of a Single Multiple Sclerosis Center
    Alldredge, Brett
    Jordan, Allison
    Imitola, Jaime
    Racke, Michael K.
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (02) : 56 - 59
  • [10] Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
    Carmen Alcalá
    F. Gascón
    F. Pérez-Miralles
    S. Gil-Perotín
    A. Navarré
    I. Boscá
    F. Coret
    B. Casanova
    Journal of Neurology, 2018, 265 : 1690 - 1697
12345